![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
Summary
Meta-analyses are popular tools to summarize the results of publications. Prognostic performances of a marker are usually summarized by meta-analyses of survival curves or hazard ratios. These approaches may detect a difference in survival according to the marker but do not allow evaluation of its prognostic capacity. Time-dependent receiver operating characteristic curves evaluate the ability of a marker to predict time-to-event. In this article, we describe an adaptation of time-dependent summary receiver operating characteristic curves from published survival curves. To achieve this goal, we modeled the marker and the time-to-event distributions using non-linear mixed models. First, we applied this methodology to individual data in kidney transplantation presented as aggregated data, in order to validate the method. Second, we re-analyzed a published meta-analysis, which focused on the capacity of KI-67 to predict the overall survival of patients with breast cancer.
References
| Parmar, M, Torri, V, Stewart, L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17(24): 2815–2834. Google Scholar | Crossref | Medline | ISI | |
| Williamson, P, Tudur Smith, C, Hutton, J. Aggregate data meta-analysis with time-to-event outcomes. Stat Med 2002; 21: 3337–3351. Google Scholar | Crossref | Medline | ISI | |
| Tierney, J, Stewart, L, Ghersi, D. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8: 1–16. Google Scholar | Crossref | Medline | ISI | |
| Dear, K . Iterative generalized least-squares for meta-analysis of survival-data at multiple times. Biometrics 1994; 50: 989–1002. Google Scholar | Crossref | Medline | ISI | |
| Arends, L, Hunink, M, Stijnen, T. Meta-analysis of summary survival curve data. Stat Med 2008; 27: 4381–4396. Google Scholar | Crossref | Medline | ISI | |
| Buckley, D, Fu, R, Freeman, M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Int Med 2009 Google Scholar | Crossref | ISI | |
| Lachenbruch, P, Rosenberg, A, Bonvini, E. Biomarkers and surrogate endpoints in renal transplantation: Present status and considerations for clinical trial design. Am J Transplant 2004; 4: 451–457. Google Scholar | Crossref | Medline | ISI | |
| Heagerty, P, Lumley, T, Pepe, S. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000; 56: 337–344. Google Scholar | Crossref | Medline | ISI | |
| Oxman, A, Clarke, M, Stewart, L. Meta-analyses using individual patient data are needed. J Am Med Assoc 1995; 274: 845–846. Google Scholar | Crossref | ISI | |
| Duchateau, L, Pignon, J, Bijnens, L. Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer. Control Clin Trial 2001; 22: 538–547. Google Scholar | Crossref | Medline | |
| de Azambuja, E, Cardoso, F, de Castro, G. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients. Br J Cancer 2007; 96: 1504–1513. Google Scholar | Crossref | Medline | ISI | |
| R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria, 2009. http://www.R-project.org. Google Scholar | |
| Pinheiro, J, Bates, D, DebRoy, S. nlme: Linear and nonlinear mixed effects models, 2009(R package version 3.1-93) Google Scholar | |
| Pocock, S, Clayton, T, Altman, D. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 2002; 359: 1686–1689. Google Scholar | Crossref | Medline | ISI | |
| Poisot, T . The digitize package: extracting numerical data from scatterplots. R Journal 2011; 3(1): 25–26. Google Scholar | ISI | |
| Trihia, H, Murray, S, Price, K. Ki-67 expression in breast carcinoma. Its association with grading systems, clinical parameters, and other prognostic factors - A surrogate marker?. Cancer 2003; 97: 1321–1331. Google Scholar | Crossref | Medline | ISI | |
| Railo, M, Nordling, S, von Boguslawsky, K. Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 1993; 68: 579–583. Google Scholar | Crossref | Medline | ISI | |
| Moses, L, Shapiro, D, Littenberg, B. Combining independent studies of a diagnostic-test into a summary ROC curve - data-analytic and some additional considerations. Stat Med 1993; 12: 1293–1316. Google Scholar | Crossref | Medline | ISI | |
| Walter, S . Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002; 21: 1237–1256. Google Scholar | Crossref | Medline | ISI | |
| Dowsett, M, Nielsen, T, A'Hern, R. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer Working Group. J Natl Cancer Inst 2011; 103: 1–9. Google Scholar | Crossref | |
| Higgins, J, Thompson, S. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558. Google Scholar | Crossref | Medline | ISI | |
| Duchateau, L, Collette, L, Sylvester, R. Estimating number of events from the Kaplan–Meier curve for incorporation in a literature-based meta-analysis: what you Don't see you can't get!. Biometrics 2000; 56: 886–892. Google Scholar | Crossref | Medline | ISI | |
| Guyot, P, Ades, A, Ouwens, M. Enhanced secondary analysis of survival data: reconstructing the data from published. BMC Med Res Method 2012; 12(9. Google Scholar | Medline | ISI |
